NFAT Induces Breast Cancer Cell Invasion by Promoting the Induction of Cyclooxygenase-2*
暂无分享,去创建一个
[1] G. Crabtree,et al. Identification of a putative regulator of early T cell activation genes. , 1988, Science.
[2] G. Crabtree,et al. Characterization of antigen receptor response elements within the interleukin-2 enhancer , 1988, Molecular and cellular biology.
[3] L. Marnett,et al. Prostaglandin and thromboxane biosynthesis. , 1991, Pharmacology & therapeutics.
[4] A. Rao,et al. Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells. , 1993, Journal of immunology.
[5] A. Ristimäki,et al. Cyclooxygenase Gene Expression in Inflammation and Angiogenesis a , 1993, Annals of the New York Academy of Sciences.
[6] T. Curran,et al. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun , 1993, Nature.
[7] P. Hogan,et al. Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[8] R. DuBois,et al. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.
[9] A. Rao,et al. Calcineurin Binds the Transcription Factor NFAT1 and Reversibly Regulates Its Activity (*) , 1996, The Journal of Biological Chemistry.
[10] R. DuBois,et al. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[11] P. Hogan,et al. Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.
[12] S. Shapiro,et al. Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma , 1998, Cancer.
[13] M. Taketo,et al. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. , 1998, Cancer research.
[14] K. Seibert,et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. , 1998, Cancer research.
[15] R. DuBois,et al. The role of cyclooxygenases in inflammation, cancer, and development , 1999, Oncogene.
[16] N. Copeland,et al. NF-AT5: the NF-AT family of transcription factors expands in a new direction. , 1999, Cold Spring Harbor symposia on quantitative biology.
[17] F. Berberich-Siebelt,et al. The role of NF-AT transcription factors in T cell activation and differentiation. , 2000, Biochimica et biophysica acta.
[18] B. Levin,et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. , 2000, The New England journal of medicine.
[19] J. Masferrer,et al. COX‐2 is expressed in human pulmonary, colonic, and mammary tumors , 2000, Cancer.
[20] J. Qin,et al. Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. , 2000, Molecular cell.
[21] R. Garavito,et al. Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.
[22] V. Steele,et al. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. , 2000, Cancer research.
[23] J. Redondo,et al. An Essential Role of the Nuclear Factor of Activated T Cells in the Regulation of the Expression of the Cyclooxygenase-2 Gene in Human T Lymphocytes* , 2000, The Journal of Biological Chemistry.
[24] A. Rao,et al. Partners in transcription: NFAT and AP-1 , 2001, Oncogene.
[25] S. Sasayama,et al. Calcineurin-GATA4 Pathway Is Involved in β-Adrenergic Agonist-responsive Endothelin-1 Transcription in Cardiac Myocytes* , 2001, The Journal of Biological Chemistry.
[26] Rajnish A. Gupta,et al. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 , 2001, Nature Reviews Cancer.
[27] L. Marnett,et al. COX-2: a target for colon cancer prevention. , 2002, Annual review of pharmacology and toxicology.
[28] J. Decaprio,et al. NFATc2-mediated repression of cyclin-dependent kinase 4 expression. , 2002, Molecular cell.
[29] J. Viola,et al. NFATC2 transcription factor regulates cell cycle progression during lymphocyte activation: evidence of its involvement in the control of cyclin gene expression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] C. Denkert,et al. Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma. , 2002, The American journal of pathology.
[31] Leslie M. Shaw,et al. The role of NFAT transcription factors in integrin-mediated carcinoma invasion , 2002, Nature Cell Biology.
[32] A. Sahin,et al. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. , 2002, Cancer research.
[33] Fan Wang,et al. Neurotrophins and Netrins Require Calcineurin/NFAT Signaling to Stimulate Outgrowth of Embryonic Axons , 2003, Cell.
[34] E. Wagner,et al. AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.
[35] K. Subbaramaiah,et al. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. , 2003, Trends in pharmacological sciences.
[36] Garret A. FitzGerald,et al. COX-2 and beyond: approaches to prostaglandin inhibition in human disease , 2003, Nature Reviews Drug Discovery.
[37] H. Okamura,et al. Ca2+/calcineurin signalling in cells of the immune system. , 2003, Biochemical and biophysical research communications.
[38] R. Brueggemeier,et al. Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes. , 2003, The Journal of clinical endocrinology and metabolism.
[39] J. Kleibeuker,et al. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas , 2003, The Lancet.
[40] Lin Chen,et al. Transcriptional regulation by calcium, calcineurin, and NFAT. , 2003, Genes & development.
[41] J. Neal,et al. A Constitutively Active NFATc1 Mutant Induces a Transformed Phenotype in 3T3-L1 Fibroblasts* , 2003, The Journal of Biological Chemistry.
[42] J. Redondo,et al. Cyclooxygenase-2: a therapeutic target in angiogenesis. , 2003, Trends in molecular medicine.
[43] Stephen P. Ethier,et al. SUM-159PT cells: a novel estrogen independent human breast cancer model system , 1999, Breast Cancer Research and Treatment.
[44] H. Joensuu,et al. Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer , 2005, Breast Cancer Research and Treatment.
[45] T. Hla,et al. Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[46] S. Ashley,et al. Prostaglandin E2 Enhances Pancreatic Cancer Invasiveness through an Ets-1-Dependent Induction of Matrix Metalloproteinase-2 , 2004, Cancer Research.
[47] Emelyn H. Shroff,et al. Nuclear Factor of Activated T Cells Balances Angiogenesis Activation and Inhibition , 2004, The Journal of experimental medicine.
[48] Min Chen,et al. Integrin α6β4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells , 2005, Oncogene.
[49] R. Cardiff,et al. HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. , 2005, Cancer research.
[50] K. Druey,et al. Prostaglandin E2 Promotes Colon Cancer Cell Growth Through a Gs-Axin-ß-Catenin Signaling Axis , 2005, Science.
[51] A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence , 2005 .
[52] M. Fresno,et al. Expression and Function of the Nuclear Factor of Activated T Cells in Colon Carcinoma Cells , 2005, Journal of Biological Chemistry.
[53] T. Hla,et al. The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia. , 2005, Cancer research.
[54] Chunxiang Zhang,et al. Blockade of Nuclear Factor of Activated T Cells Activation Signaling Suppresses Balloon Injury-induced Neointima Formation in a Rat Carotid Artery Model* , 2005, Journal of Biological Chemistry.
[55] Chad A. Corcoran,et al. Cyclooxygenase-2 interacts with p53 and interferes with p53-dependent transcription and apoptosis , 2005, Oncogene.
[56] P. Sismondi,et al. Breast cancer and sex steroids: Critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer , 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.